Ketamine and Neurofeedback as Combined Therapeutic Interventions to Target Glutamatergic Neurotransmission in Alcohol Use Disorder

Clinical trial NCT06969937 · RECRUITING

Trial details

NCT number: NCT06969937
Sponsor: Dr. med. Marcus Herdener
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Alcohol Abuse/Dependence Alcohol Use Disorder (AUD)Alcoholism

Start date: 2025-06-01
Primary completion: 2026-12-01
Enrollment: 75

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.